A retrospective cohort study: do patients with graves’ disease need to be euthyroid prior to surgery? by Abrar Al Jassim, Tim Wallace, Sarah Bouhabel, Agnieszka Majdan, Michael Hier, Veronique-Isabelle Forest, Richard Payne

Get full text

Development and validation of the modified index of fragility in head and neck cancer surgery by Koorosh Semsar-Kazerooni, Keith Richardson, Véronique-Isabelle Forest, Alex Mlynarek, Michael P. Hier, Nader Sadeghi, Marco. A. Mascarella

Get full text

The T4/T3 quotient as a risk factor for differentiated thyroid cancer: a case control study by Mark Sasson, Emily Kay-Rivest, Rami Shoukrun, Anca Florea, Michael Hier, Veronique-Isabelle Forest, Michael Tamilia, Richard J. Payne

Get full text

EIF1AX mutation in thyroid tumors: a retrospective analysis of cytology, histopathology and co-mutation profiles by Noha Elsherbini, Dong Hyun Kim, Richard J. Payne, Thomas Hudson, Véronique-Isabelle Forest, Michael P. Hier, Alexandra E. Payne, Marc P. Pusztaszeri

Get full text

Molecular testing for cytologically suspicious and malignant (Bethesda V and VI) thyroid nodules to optimize the extent of surgical intervention: a retrospective chart review by Jessica Hier, Galit Avior, Marc Pusztaszeri, Joshua R. Krasner, Noura Alyouha, Veronique-Isabelle Forest, Michael P. Hier, Alex Mlynarek, Keith Richardson, Nader Sadeghi, Michael Tamilia, Richard J. Payne

Get full text